AstraZeneca shares rise as China probe update reassures
07 Feb 2025 //
REUTERS
BMS Adds $2B to Cost Cutting Plans, Eyes Deals After Cobenfy Success
07 Feb 2025 //
BIOSPACE
GSK questions Gilead`s potential dominance of the PrEP market
07 Feb 2025 //
FIERCE PHARMA
AstraZeneca CEO defends `fantastic` Alexion buy as halts drug
07 Feb 2025 //
FIERCE BIOTECH
Pfizer builds out new oncology team with Legos
07 Feb 2025 //
PRESS RELEASE
Cancer vaccine prevents kidney cancer comeback in small trial
07 Feb 2025 //
FIERCE BIOTECH
Kura, Kyowa hail ph. 2 win for leukemia drug, but hold back data
07 Feb 2025 //
FIERCE BIOTECH
Novo fails trial, linking obesity asset to psychiatric effects
06 Feb 2025 //
FIERCE BIOTECH
GSK launches $2.5 billion buyback, lifts sales target
06 Feb 2025 //
PRESS RELEASE
Drugs In Development

Market Intel
